These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 420953)

  • 21. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.
    Manni A; Trujillo JE; Pearson OH
    Cancer Treat Rep; 1980 Jan; 64(1):111-6. PubMed ID: 6155207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of high-dosage attack treatment with cytostatics in mammary and ovarian cancer (author's transl)].
    Möhlen KH; Beller FK
    Strahlentherapie; 1978 Sep; 154(9):622-6. PubMed ID: 684782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W; Nagel G; Senn HJ
    Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combination chemotherapy in the treatment of polymetastic breast cancer. Comparison of therapeutic effects of 2 methods of sequential drug administration. Role of adriamycin in these combinations].
    Pouillart P; Schwarzenberg L; Palangie T; Belpomme D; Mathé G; Huguenin P; Morin P; Gautier H; Laparre C; Baron A
    Nouv Presse Med; 1976 Oct; 5(9 Oct 76):2145-50. PubMed ID: 980774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy in primary and metastatic intrathoracic cancer].
    Mannes P; Derriks R; Moens R; Laurent C
    Ann Med Interne (Paris); 1976 Jan; 127(1):25-34. PubMed ID: 1008360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of head and neck carcinomas. Association of adriamycine, vincristine and methotrexate (author's transl)].
    Durand M; Chauvergne J; Renaud-Salis JL
    Ann Otolaryngol Chir Cervicofac; 1980; 97(4-5):277-83. PubMed ID: 7406411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Vilcoq JR; Bataini JP; Calle R; Fenton J; Mathieu G; Rousseau J; Asselain B
    Bull Cancer; 1981; 68(2):171-86. PubMed ID: 7016224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polychemotherapeutic treatment of advanced breast cancer.
    Brown I; Arthur K; Banks AJ; Bond WH; Chowdhury MS; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ward HW
    Clin Oncol; 1977 Jun; 3(2):183-9. PubMed ID: 872472
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
    Bonadonna G; Zambetti M; Moliterni A; Gianni L; Valagussa P
    J Clin Oncol; 2004 May; 22(9):1614-20. PubMed ID: 15117983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
    Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
    Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers].
    Pouillart P; Schwarzenberg L; Amiel JL; Mathé G; Huguenin P; Morin P; Baron A; Laparre Ch; Parrot R
    Nouv Presse Med; 1975 Mar; 4(10):713-6. PubMed ID: 1129034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
    Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
    Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
    Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
    Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.